Skip to content
    Drishti.money
    Earnings calls

    Zydus Lifesci. concall ledger

    Every earnings call for ZYDUSLIFE — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    ZYDUSLIFE · 5 transcripts · Healthcare · latest Q4 FY26
    Q4 FY26Published 19 May 2026Call held 19 May 2026

    ZYDUSLIFE Q4 FY26 Earnings Call Transcript & Analysis

    Consolidated EBITDA84.8 billion+20% YoYEBITDA Margin31.2%Adjusted Net Profit54.6 billion+15% YoY

    Consolidated EBITDA (FY26) 84.8 billion (+20% YoY); EBITDA Margin (FY26) 31.2%; Adjusted Net Profit (FY26) 54.6 billion (+15% YoY). FY26 consolidated revenues grew 17% YoY to ₹271.5 billion.

    Read full transcript & analysis
    Q3 FY26Published 10 Feb 2026Call held 10 Feb 2026

    ZYDUSLIFE Q3 FY26 Earnings Call Transcript & Analysis

    Consolidated Revenue₹6,860 cr+30% YoYConsolidated EBITDA₹1,820 cr+31% YoYConsolidated EBITDA Margin26.5%Adjusted Net Profit₹1,110 cr+9% YoY

    Consolidated Revenue ₹6,860 cr (+30% YoY); Consolidated EBITDA ₹1,820 cr (+31% YoY); Consolidated EBITDA Margin 26.5% (+0% YoY). Consolidated revenues of ₹68.6 billion, up 30% YoY.

    Read full transcript & analysis
    Q4 FY25Published 27 May 2025Call held 27 May 2025

    ZYDUSLIFE Q4 FY25 Earnings Call Transcript & Analysis

    Consolidated Revenue232.4 billion rupees+19% YoYConsolidated EBITDA70.6 billion rupees+31% YoYEBITDA Margin32.6%Net Profit47.5 billion rupees+22% YoY

    Consolidated Revenue (FY25) 232.4 billion rupees (+19% YoY); Consolidated EBITDA (FY25) 70.6 billion rupees (+31% YoY); EBITDA Margin (Q4 FY25) 32.6%. FY25 consolidated revenues grew 19% YoY to ₹232.4 billion.

    Read full transcript & analysis